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Abstract
Susceptibility of sheep to scrapie, a transmissible spongiform encephalopathy of small ruminants, is strongly
influenced by polymorphisms of the prion protein gene (PRNP). Breeding programs have been implemented to
increase scrapie resistance in sheep populations; though desirable, a similar approach has not yet been applied in
goats. European studies have now suggested that several polymorphisms can modulate scrapie susceptibility in
goats: in particular, PRNP variant K222 has been associated with resistance in case-control studies in Italy, France
and Greece. In this study we investigated the resistance conferred by this variant using a natural Italian goat
scrapie isolate to intracerebrally challenge five goats carrying genotype Q/Q 222 (wild type) and five goats carrying
genotype Q/K 222. By the end of the study, all five Q/Q 222 goats had died of scrapie after a mean incubation
period of 19 months; one of the five Q/K 222 goats died after 24 months, while the other four were alive and
apparently healthy up to the end of the study at 4.5 years post-challenge. All five of these animals were found to
be scrapie negative. Statistical analysis showed that the probability of survival of the Q/K 222 goats versus the Q/Q
222 goats was significantly higher (p = 0.002). Our study shows that PRNP gene mutation K222 is strongly
associated with resistance to classical scrapie also in experimental conditions, making it a potentially positive target
for selection in the frame of breeding programs for resistance to classical scrapie in goats.
Introduction
Scrapie is a naturally occurring transmissible spongiform
encephalopathy (TSE) of sheep and goats, characterized
by the accumulation in the central nervous system
(CNS) of an abnormal isoform (PrPSc) of a host-encoded
cellular prion protein (PrPC) [1]. Natural scrapie in goats
was first reported in France [2], followed by other cases
worldwide: a state of the art review on goat scrapie in
the European Union, including its epidemiology, was
published by Vaccari et al. [3]. Goats are susceptible not
only to classical scrapie, but also atypical/Nor98 scrapie
cases have been detected. As in sheep, it is characterized
by distinctive features in epidemiology (i.e., occurrence
as single cases in the affected herds), molecular pattern,
and distribution of histopathological changes [3]. More-
over, the only two confirmed cases of natural bovine
spongiform encephalopathy (BSE) in small ruminants
were reported in goats in France [4] and in a retrospec-
tive study in the UK [5].
The first Italian case of scrapie in the goat was diag-
nosed in 1997 [6]; since then, 65 outbreaks have
occurred (51 of classical scrapie and 14 of Nor98 scra-
pie), in which 13 000 goats were culled in accordance
with the foreseen measures for eradication of the
disease.
Although an infectious disease, the susceptibility of
sheep to scrapie is strongly influenced by polymorph-
isms of the prion protein gene (PRNP). PRNP haplotypes
valine/arginine/glutamine (VRQ) and alanine/arginine/
glutamine (ARQ) at codons 136, 154, 171, respectively,
are associated with high susceptibility to classical scra-
pie, whereas the ARR haplotype has been linked to
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resistance [7-10]. Accordingly, the EU has implemented
breeding programs to increase scrapie resistance in
sheep populations. In compliance with regulation (EC)
999/2001, as amended, several Member States are now
increasing the frequency of the ARR haplotype. A simi-
lar approach has not yet been applied in goats, but it
would be desirable in this species too, given that scrapie
poses a problem for the economy and animal welfare,
and that goats, often bred in mixed flocks with sheep,
can play a role in maintaining the circulation of scrapie
strains and the consequent sheep exposure. Genetic ana-
lysis of the goat PRNP gene revealed 46 polymorphisms
in the open reading frame [3,11], including silent muta-
tions and a PRNP variant containing three instead of the
five usual octapeptide repeats [12]. Various European
studies have suggested that several polymorphisms can
modulate scrapie susceptibility in goats as well. The pre-
sence of methionine (M) at codon 142 is associated with
increased incubation periods after experimental chal-
lenge of BSE and scrapie strains [13] and in natural
scrapie outbreaks [14,15]. A reduced susceptibility to
natural scrapie has also been reported for goats carrying
arginine (R) at codon 143, histidine (H) at codon 154
[16,17] or glutamine (Q) at codon 211 [14]. However,
H154 has clearly been suggested to be a risk factor for
Nor98 goat scrapie [18]. The most promising results
have been obtained for codon 146, carrying serine (S) or
aspartic acid (D), which is linked to high resistance in
Cyprus [19,20], and for codon 222, carrying lysine (K),
which in Italy was first reported as conferring resistance
and has only been associated with healthy animals
[16,21]. An association of K222 with a protective effect
was also later found in France and Greece [14,22].
Taken together, these results provide encouraging evi-
dence for the support of breeding programs for resis-
tance in goats against classical scrapie in all EU Member
States, as stated by the EFSA Panel on Biological
Hazards in the “Opinion on genetic TSE resistance in
goats in all EU Member States” [23], and perhaps also
in other non-EU countries. In such a prospective, it is
essential to reinforce existing data from field studies
with those from experimental studies, particularly those
carried out with the experimental transmission of differ-
ent TSE isolates in goats harbouring the PRNP alleles of
interest.
In this study, we investigated the resistance given by
mutation K222 by intracerebrally challenging two
groups of goats, with and without the considered allele,
using a natural Italian goat scrapie isolate. Our study
confirms the highly protective effect of K222 against
classical scrapie. Furthermore, being the first scrapie
transmission study carried out in goats in Italy, it pro-
vides information on clinical signs and PrPSc distribu-
tion patterns in goats affected by an Italian scrapie
strain.
Materials and methods
Animals and animal care
Ten four-month-old goats were purchased from two
herds with no record of scrapie cases in the last five
years: six animals were Camosciata cross-bred and four
were dwarf goat cross-bred. The animals were chosen
on the basis of their genotype and having been born in
northern Italy near the study site. This was done to
avoid problems of stress due to long transport or cli-
matic changes. The animals were previously genotyped
at the PRNP locus, as described below, and two groups
were formed: one group consisted of five animals het-
erozygous for Q/K at codon 222, and one group of five
wild type Q/Q 222 animals, with a mixed assortment of
the genotype at codon 240 (Table 1). No K/K 222 goats
were found. In both groups there were three Camosciata
cross-bred and two dwarf goat cross-bred animals. No
other mutations were present in the PRNP gene of these
animals, except for the two Q/Q 222 dwarf goat cross-
bred animals that presented a deletion of two octare-
peats, thus being 3/5 heterozygous for the octapeptide
repeats. These animals were included in the study to
also gather information on the possible resistance con-
ferred by this deletion, as hypothesized by Goldmann et
al. [12]. The animals were kept in the facility for one
month before challenging to allow them to adapt to the
new environment and to exclude the presence of other
diseases. During the experiment, they were all kept in
the same room to expose them to identical environmen-
tal conditions. All procedures involving the animals and
their care were conducted in conformity with national
and international laws and policies (EEC Council Direc-
tive 86/609, OJL358, 1, 12 December 1987; Italian Legis-
lative Decree 116/92, Gazzetta Ufficiale della Repubblica
italiana 10, 18 February 1992; and Guide for the Care
and Use of Laboratory Animals, U.S. National Research
Council, 1996).
Genetic analysis
Genomic DNA was isolated from EDTA-treated blood
samples using Thermo Labsystems KingFisher kits
(Thermo LabSystems Inc., Beverly, MA, USA). PCR
amplification of the entire open reading frame of the
PRNP gene was performed according to a previously
described protocol [24] using the primers p8(+) (5’-
CAGGTTAACGATGGTGAAAAGCCACATAGG-3’)
and p9(-) (5’-GGAATTCTATCCTACTATGA-
GAAAAATGAGG-3’) [8]. PRNP polymorphisms were
detected by direct DNA sequencing on both strands of
the PCR products by using dye terminator cycle sequen-
cing and an ABI Prism 3130 Genetic Analyser (Applied
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Biosystems, Carlsbad, CA, USA). Sequencing primers
were p8(+), p61(+) (5’-AACCAACATGAAG-
CATGTGG-3’), p60(-) (5’-GATAGTAACGGTCCTCA-
TAG-3’) and p9(-)[7]. The primers were hybridized to
the target PRNP DNA at codons 1-7, 109-116, 147-154
and 249-257, respectively, (ovine reference sequence
GenBank accession number AJ000739).
Inoculum preparation and inoculation
The inoculum was prepared from the brain tissue of a
female goat affected by natural classical scrapie (accord-
ing to the approved discriminatory immunoblot carried
out by the Istituto Superiore di Sanità, Rome, Italy) with
genotype of the PRNP gene heterozygous at codon 240
(S/P) and with no other mutations. The inoculum was
ground in a mechanical grinder and homogenized with
normal sterile saline solution to a final concentration of
10% (w/v). A solution of penicillin and streptomycin
was added to the inoculum prior to use and the homo-
genate was checked for microbiological sterility. Just
prior to inoculation, the animals were clinically exam-
ined to rule out clinical abnormalities. Intracerebral
inoculation of the kids was performed as previously
described [25] with minor modifications. Briefly, the ani-
mals were anaesthetized with xylazine (50 μg/kg) and, in
surgical aseptic conditions, a midline incision was made
in the skin at the junction of the parietal and frontal
bones and a 1 mm hole was drilled through the calvar-
ium. The inoculum (0.5 mL of 10% w/v brain homoge-
nate) was injected into the midbrain through a 22
gauge, 9 cm long needle while withdrawing the needle
from the brain. The skin incision was closed with a sin-
gle suture. The inoculated animals were housed together
in a bio-safety level 3 containment facility.
Clinical evaluation
Clinical evaluation comprised daily observation and
biweekly physical assessment carried out by the animal
husbandry staff and the veterinarian, respectively. Neu-
rologic examination was performed monthly by a board-
certified neurologist. For this purpose, a clinical exami-
nation protocol, previously used for sheep [26], was
applied. The protocol followed the standard procedure
for assessing mental status, posture, gait, postural reac-
tions and proprioception, cranial nerves, spinal reflexes
and sensitivity. Sensitivity to external stimuli was evalu-
ated by light and acoustic response, as described for
BSE [27], wherein an animal was considered hyperreac-
tive if it showed an exaggerated response three times in
a row. The nibble reflex was defined as positive if the
animal showed head and neck extension, chewing move-
ments associated with head and tongue movements after
being manually stimulated on the withers and lumbosa-
cral areas.
An animal was considered symptomatic (onset of
symptoms) if it showed at least two of the following cri-
teria: abnormal fleece, abnormal mental status/beha-
viour, abnormal gait, abnormal postural reaction/
propioception and positive nibble reflex. Neurologic
examinations were intensified according to the onset of
Table 1 Goats included in the study: survival time and duration of symptoms after i.c. challenge.
Ear tag Sex Breed Genotype Scrapie positivity Survival time (days) Symptomathology duration (days)
1 F Camosciata cross-bred Q/Q222
P/P240
yes 553 5
12 F Dwarf goat cross-bred 3/5 repeats
Q/Q222
S/P240
yes 539 23
14 M Dwarf goat cross-bred 3/5 repeats
Q/Q222
S/P240
yes 539 13
18 F Camosciata cross-bred Q/Q222
S/P240
yes 477 14
VA2 F Camosciata cross-bred Q/Q222
S/S240
yes 734 2
Mean value: 569 (± 97)
7 M Dwarf goat cross-bred Q/K222
S/P240
no 1643 /
14R F Camosciata cross-bred Q/K222
S/S240
no 720 /
17 F Dwarf goat cross-bred Q/K222
S/S240
no 1643 /
29 F Camosciata cross-bred Q/K222
S/P240
no 1643 /
32 F Camosciata cross-bred Q/K222
S/P240
no 1643 /
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symptoms. Animals that became inappetant or tended
toward recumbency were humanely euthanized.
Tissue sample collection
After general anaesthesia with propofol (PropoVet®,
Abbott, Illinois, USA) administered intravenously (i.v.),
the animals were euthanized with i.v. injected Enbutra-
mide/Mebezonium iodide/Tetracaine hydrochloride
(Tanax®, Intervet Inc. Merck, Summit, NJ, USA). After
culling of the animals, the whole brain, the entire spinal
cord, and the lymph reticular system were collected and
divided into two halves, one was frozen at -80°C for
immunoblot analyses and the other was fixed in 4% buf-
fered formalin for immunohistopathological examina-
tions. A further panel of peripheral organs and tissues
was collected and frozen at -80°C for immunoblot ana-
lyses (Table 2).
Immunoblot analysis
Pre-treatment for extraneural tissues
Extraneural tissues, not including the spleen, were cut
into small pieces by means of scalpels and incubated in
a PBS-1% trypsin solution overnight at room tempera-
ture (RT) under gentle agitation. After incubation, the
tissues were rinsed with ultrapure water [28]. From the
authors’ experience, trypsin digestion did not reduce the
amount of detectable PrPsc.
PrP extraction method
Ten percent (w/v) homogenates from different brain
areas and extraneural tissues were prepared in lysis buf-
fer (10% N-lauroylsarcosine diluted in Tris Buffer Saline
pH 7.4) and clarified by centrifugation at 22 000 g for
20 min at 10°C (Ultracentrifuge Optima TLX, Rotor
TLA 55, Beckman Coulter, Fullerton, CA, USA). For
extraneural tissues a further step was added in which
supernatant was collected and incubated with benzonase
nuclease 50 meq/mL (Novagen, San Diego, CA, USA)
for 30 min at 37°C. The supernatants were incubated
with proteinase K (PK; 40 μg/mL; Sigma Aldrich, Poole,
Dorset, UK) for 1 h at 37°C under continuous shaking.
After centrifugation at 215 000 g for 1 h at 10°C (Ultra-
centrifuge Optima TLX, Rotor TLA 110, Beckman Coul-
ter), the pellet was dissolved in Laemmli buffer and
boiled for 10 min at 99°C.
Electrophoresis and immunodetection method
Samples were subjected to sodium dodecyl sulphate
polyacrilamide gel electrophoresis on a 12% handmade
minigel (acrylamide/bisacrylamide ratio 37.5:1) and then
transferred to a polyvinylidene fluoride membrane
(PVDF) (Immobilion P, Millipore, Billerica, MA, USA)
by wet blotting. PrPSc was detected by the P4 (0.1 μg/
mL; R-Biopharm, Darmstadt, Germany) [29] monoclonal
antibody and an anti-mouse antiserum conjugated with
alkaline phosphatase. Reaction was revealed by a chemi-
luminescent substrate (Immun-Star, Bio-Rad, Hercules,
CA, USA) and visualised on Hyperfilm ECL (GE-Health-
care Ltd., St. Giles, UK) or by a gel documentation ana-
lysis system (UVI Prochemi, Uvitec, Cambridge, UK).
Comparison of the molecular masses of the PrPSc bands
was carried out on the inoculated goats and inoculum
sample. For quantitative study of the glycoform ratios,
chemiluminescent signals corresponding to the three
glycoforms of PrPSc were quantified using a UVI Pro-
chemi analysis system. Glycoform ratios were expressed
Table 2 Tissues collected at necropsy.
Central nervous
system
Lymph reticular
tissues
Respiratory tract Gastro-
intestinal tract
Muscles Miscellaneous
Encephalon Tonsil Trachea Salivary glands Tongue Eye
Cerebellum Retropharyngeal
lymph node
Lung Esophagus Masseter muscle Kidney
Brainstem Mandibular lymph
node
Olfactory tract at nasal septum, ethmoturbinates and
ventral nasal concha
Liver Biceps brachii
muscle
Urinary
bladder
Cervical spinal
cord
Mesenteric lymph
node
Rumen Triceps femoris
muscle
Mammary
gland
Thoracic spinal
cord
Spleen Omasum Heart Adrenal gland
Lumbar spinal
cord
Third eyelid
lymphoid tissue
Reticulum
Abomasum
Duodenum
Jejunum
Ileum
Ileo-ciecal valve
Caecum
Rectum
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as mean percentages of the total signal for the three gly-
coforms (di-, mono-, and un-glycosylated) from three
different runs of the samples.
PrPSc quantification
In order to estimate the relative concentration of PrPSc
in some positive extraneural organs (skeletal muscle,
intestinal tract, omasum, abomasum, kidney), the signal
intensity was quantified. Specifically, we compared the
intensity of the proteinase-K digested positive signals
with calibration curves obtained by diluting the corre-
sponding brainstem of the scrapie-positive goat with
scrapie-negative homogenates of the above-mentioned
extraneural tissues. This comparison was done with
three of the scrapie-positive animals. The extraction
method and immunoblot technique were identical to
those previously described. Quantification analyses were
performed using the UVI Prochemi gel documentation
and analysis system.
Immunohistochemical analysis
Immunohistochemical investigations for PrPSc were per-
formed on each brain area and lymph reticular tissue.
Four-μm-thick sections of each formalin-fixed, paraffin-
embedded specimen were cut. The slides were dewaxed
and rehydrated by routine methods and then immersed
in 98% formic acid for 25 min. After washing in distilled
water, the sections were autoclaved for 30 min at 121°C
in citrate buffer (pH 6.1). Endogenous peroxidase activity
was blocked in 3% hydrogen peroxide for 20 min at RT.
To block non-specific tissue antigens, the sections were
incubated with 5% horse blocking serum for 20 min at
RT and then incubated for 1 h at RT with primary mono-
clonal antibody L42 (epitope GNDYEDRYYRENMYR-
YPNQ, amino acids 145 to 163 of the ovine PrP, 1: 250
dilution; RIDA, R-Biopharm, Darmstadt, Germany) [30].
After rinsing, a biotinylated goat anti-mouse secondary
antibody (1: 200 dilution; Vector Laboratories, Burlin-
game, CA, USA) was applied to the tissue sections for 30
min at RT, followed by the avidin-biotinperoxidase com-
plex (Vectastain ABC kit; Vector Laboratories), according
to the manufacturer’s protocol. PrPSc immunoreactivity
was visualized using 3,3’-diaminobenzidine (Dakocyto-
mation, Carpinteria, CA) as a chromogen; the sections
were then counterstained with Meyer’s haematoxylin. In
case of a positive result, specificity was checked by repla-
cing the primary antibody by normal serum.
Statistical analysis
Survival times between the two groups were compared
using Kaplan-Meier survival estimates. The difference in
the probability of survival was analyzed using the log-
rank test for equality of survivor functions.
Results
By the end of the study, all the susceptible Q/Q 222
goats had died or been euthanized for animal welfare
after a mean incubation period of 19 months (569 ± 97
days). Survival times are shown in Table 1. All were
shown to be scrapie positive by both immunoblot and
immunohistochemistry. In the group of supposedly
resistant Q/K 222 goats, one animal died of unknown
cause 24 months into the study. All the other animals
were alive and apparently healthy up to the end of the
study, when they were euthanized, i.e., at 4.5 years post-
challenge (Table 1). All five animals, including the one
dead at 24 months post-challenge, were shown to be
scrapie negative by immunoblot and immunohistochem-
istry of both the CNS and the lymph reticular system.
Statistical analysis shows that the probability of survival
of the Q/K 222 goats versus the Q/Q 222 goats was sig-
nificantly higher (c2= 9.34, p = 0.002).
At clinical examination, three animals (ear tag 18, 1
and VA2) showed itching, skin lesions, depressed mental
status, wide base stance, tremors, ataxia, weakness and
abnormal postural reactions/proprioception. Two ani-
mals (ear tag 12 and 14) developed, in addition to skin
lesions, depression and tremors, a central vestibular syn-
drome manifested by head tilt, wide base stance, asym-
metrical ataxia and circling, ipsilateral paresis and
proprioceptive deficits, vertical nystagmus, positional
strabismus, bilaterally decreased menace reaction and
normal palpebral reflex. Table 1 reports the duration of
the symptoms.
All five Q/Q 222 animals tested positive for the CNS
and the large part of the lymph reticular system ana-
lysed both by Western blot and immunohistochemistry.
Moreover, the peripheral nerves and numerous extra-
neural organs tested scrapie positive by Western blot
(Table 3). Molecular analysis of PrPSc of the inoculated
goats and the inoculum sample revealed a similar elec-
trophoretic pattern characterized by three bands corre-
sponding to the di-, mono- and un-glycosylated forms,
with a molecular weight of 30, 25 and 20 kDa, respec-
tively. The mean (± standard deviation [SD]) di-, mono-
and un-glycosylated band intensity was 48.16 ± 2: 31.86
± 2: 19.98 ± 1.9, respectively, for the inoculated goats
and 49.27 ± 1.5: 32.19 ± 1.1: 18.54 ± 2, respectively, for
the inoculum sample. Quantification showed that the
PrPSc signal intensity in the positive muscular tissues
was generally similar to that obtained when five milli-
grams of the corresponding positive brainstem homoge-
nate were diluted in five grams of a negative muscle
homogenate. From this finding, we estimated that the
PrPSc levels in the three examined cases were lower
than those found in the corresponding brainstems by a
factor of approximately 1 × 10-3. The signal intensities
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Table 3 Results of Wb and IHC analyses of the Q/Q 222 goats.
Apparatus Central Nervous System Peripheral Nervous System
Organs/
Tissues
Brainstem Cerebellum Occipital
cortex
Parietal
cortex
Temporal
cortex
Frontal
cortex
Pyriform
lobus
Mesence
-
phalon
Talamus Basal
nuclei
Cervical
spinal
cord
Thoracic
spinal
cord
Lumbar
spinal
cord
Optic
nerve
Brachial
nerve
Sciatic
nerve
ID
sample
#1 + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
#12 + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
#14 + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
#18 + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
#VA2 + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
positive/
tested
5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5 5/5
method Wb IHC Wb IHC Wb IHC Wb IHC Wb IHC Wb IHC Wb IHC Wb IHC Wb IHC Wb IHC Wb IHC Wb IHC Wb IHC Wb Wb Wb
Apparatus Lymph reticular System Respiratory tract Digestive apparatus
Organs/
Tissues
Tonsil Mandibular
lymph node
Retro-
pharingeal
lymph
node
Mesenteric
lymph
node
Spleen Ileo-
ciecal
valve
Third
eyelid
Olfactory
tract
Trachea Lung Salivary
glands
Esophagus Liver Rumen Omasum Reticulum
ID
sample
#1 + + + + + + + + + + + + + + + - - + + - - + +
#12 + + + + + + + + + + + - - - + - - - + - - + +
#14 + + + + + - + + + + + + - - + - - - - - - + +
#18 + + + + + + + + + + + + + + + - - - - - - - -
#VA2 + + + + + + + + + + + + - - - - - - - - - - -
positive/
tested
5/5 5/5 5/5 5/5 5/5 4/5 5/5 5/5 5/5 5/5 5/5 4/5 2/5 2/5 4/5 0/5 0/5 1/5 2/5 0/5 0/5 3/5 3/5
method Wb IHC Wb IHC Wb IHC Wb IHC Wb IHC Wb IHC Wb IHC Wb Wb Wb Wb Wb Wb Wb Wb Wb
Apparatus Gastrointestinal tract Muscles Miscellaneous
Organs/
Tissues
Abomasum Duodenum Jejunum Ileum Caecum Rectum Tongue Masseter
muscle
Biceps
brachii
muscle
Triceps
femoris
muscle
Heart Eye Kidney Urinary
bladder
Mammary
gland
Adrenal
gland
ID
sample
#1 - + + + + + - + + + - + + + - -
#12 - + + + + + + + + + + + - - - -
#14 - + + + + + + - - + + + - - / -
#18 - - - - - - - - - - - - - - - -
#VA2 - + + + + - + - - - - - - - - -
positive/
tested
0/5 4/5 4/5 4/5 4/5 3/5 3/5 2/5 2/5 3/5 2/5 3/5 1/5 1/5 0/4 0/5
method Wb Wb Wb Wb Wb Wb Wb Wb Wb Wb Wb Wb Wb Wb Wb Wb
+: positive result; -: negative result
A
cutis
et
al.Veterinary
Research
2012,43:8
http://w
w
w
.veterinaryresearch.org/content/43/1/8
Page
6
of
10
of the positive omasum, abomasum and kidney were
usually lower than those found in the corresponding
brainstems by a factor of 1 × 10-3 - 1 × 10-4.
The Q/K 222 goats were completely negative by
immunoblot analysis of all extraneural tissues and
organs.
Discussion
Our study shows that PRNP gene mutation K222 is
strongly associated with resistance to classical scrapie in
experimentally challenged goats, confirming the results
previously obtained in field studies [16,21]. The Q/K
222 goats arrived as healthy, scrapie negative until the
end of the study, with a significantly longer survival
time of about three years compared to the Q/Q 222
inoculated goats. The study had to be necessarily con-
cluded, but the survival time of 1643 days (i.e. 4.5
years), which is nearly equal to the average economic
lifespan of a goat in Italy (i.e. five years), was long
enough to allow the hypothesis for a high level of resis-
tance, even if a minimal susceptibility or a very pro-
longed incubation period (i.p.) cannot be excluded.
Admittedly, the transmission of infection was carried
out in conditions where the host barriers were reduced
to a minimum, via the intracerebral route and by inocu-
lating with a goat natural scrapie isolate that was thus
already adapted to the species. Nonetheless, the Q/K
222 goats remained healthy for a longer period than the
i.p. reported in other transmission studies in goats and
sheep. Heterozygous goats with the partial resistance-
associated M142 mutation succumbed much earlier, at
984-985, 675-894 and 640-895 days, after i.c. transmis-
sion of BSE, sheep scrapie CH1641 and sheep-passaged
ME7, respectively. In wild type goats, instead, the same
strains had an i.p. similar to that obtained in the present
study [13]. Similarly, Foster et al. [31] reported in wild
type goats i.c. challenged with natural scrapie and BSE,
an i.p. of 362-517 and 506-570 days, respectively. In
sheep, i.c. BSE challenged ARR/ARR animals showed an
i.p. of 1008-1127 days post-infection [32]. However,
because our study showed the resistant goats still
healthy, it cannot be excluded that they might have
remained scrapie negative for their entire normal life
span.
The results of the challenge of the Q/Q 222 goats
yielded further interesting information on goat scrapie
genetics. The two goats carrying the octarepeat deletion
died of scrapie, with an i.p. not unlike that of the other
goats in the same group, showing that in our sample
this mutation did not confer any resistance, on the con-
trary to that which was hypothesized by Goldmann [12],
perhaps because of the scrapie strain used in the experi-
ment. It is noteworthy that one Q/Q 222 goat (VA2)
died after an i.p. nearly 200 days longer than that of the
rest of the same group. This goat had no other mutation
on the PRNP gene, but it was the only one out of its
group that was homozygote for serine at codon 240.
While this prolonged i.p. in one animal does not allow
us to say whether it was significant or just happened by
chance, we can speculate that other unknown genetic
factors may have come into play or that indeed serine at
codon 240 could have had an effect. Field studies have
produced controversial results about codon 240, indicat-
ing a positive association with scrapie infection of P240
[21] or a positive association with clinical disease of
S240 [22] or no association [13,16,17]. Interestingly,
Goldmann et al. [13] reported that a BSE orally chal-
lenged S/S 240 goat had an i.p. 500 days longer than an
S/P240 goat. Barillet et al. [14] found that mutation
M142 in heterozygotes conferred a protective effect only
when in association with P/P 240 homozygotes.
Although codon 240 is generally not believed to influ-
ence scrapie susceptibility, it could exert an effect, per-
haps depending on the scrapie strain involved.
The clinical signs seen in three of the five scrapie
positive animals were similar to those previously
described in both experimental and natural scrapie, but
none of the animals in the present study showed aggres-
siveness, hypersensitivity to external stimuli or hyperex-
citability. As already known in goats, unlike that
observed in sheep with scrapie, [31,33-35], scratching of
the animal’s back did not elicit the nibble reflex in any
goat. Worth noting was the lateralization of clinical
signs in the two remaining animals (ear tag 12 and 14),
suggesting an involvement of the vestibular system. His-
topathological examination of the brain ruled out a sec-
ondary disease that could have caused the asymmetrical
clinical presentation. A vestibular syndrome in two
goats with classical scrapie was described by Konold et
al. [34]. This atypical clinical presentation stresses the
importance of not excluding scrapie on the basis of
lateralization of neurological signs in experimental and
field conditions.
Since the route of inoculation differed from that of the
natural disease, no conclusions on the pathogenesis of
scrapie in goats can be drawn from the pattern of PrPSc
distribution in the extraneural tissues; nonetheless, it
does give information on the centrifugal diffusion of
PrPSc, which may prove useful for risk assessment of
human exposure given by peripheral districts. Our
results are in line with previous observations in goats
and sheep with natural scrapie or after oral challenge. It
appears that PrPSc had a widespread distribution, similar
to that observed in sheep, involving the lymph reticular
system, as already known in goats [36], and other dis-
tricts, some of which have never been reported in goats
so far, such as the omasum, abomasum, kidney and the
olfactory system, have already been reported to be sites
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of PrPSc deposition in sheep [37,38,28]. Similarly to what
has been found recently in naturally affected sheep and
goats [39], scrapie positivity was not found in the third
eyelid or the rectal mucosa in all the animals, highlight-
ing the limitation of using those districts for preclinical
diagnosis, as recently proposed [40,41].
The finding of positive signals in the skeletal muscles
in three of the five scrapie-positive goats is consistent
with reports of muscle tissues that tested positive in a
scrapie i.c. challenged goat [42] and orally challenged
goats older than 21 months [43]. The PrPSc amount,
compared to that in the brainstem, was at least 1000-
fold lower in the muscles and 1000 to 10 000-fold lower
in the omasum, abomasum and kidney, suggesting a low
risk for human transmission by these tissues.
After identifying a genetic variant associated with TSE
resistance, the main question is the validity of the asso-
ciation in relation to different classical scrapie strains,
atypical scrapie and BSE. Our study confirms that var-
iant K222 of the goat PRNP gene can be a genetic target
to select for in the frame of breeding programs for the
control and eradication of classical scrapie in goats. This
result is certainly mainly valid for Italy, given that an
Italian scrapie isolate was used in the experiment. The
situation in Italy could be particularly favorable because
there is good evidence for a low variability of circulating
scrapie strains [44,45]. The association of K222 with
resistance found in field studies in France and Greece
indicates that this variant can probably confer resistance
to several classical scrapie strains. Moreover, a recent
study showed that cell-free conversion of recombinant
PrP was completely abolished in the presence of the
recombinant K222 variant, using mouse scrapie strain
ME7 [46]. On the contrary, some positive Q/K 222
goats were recently detected in Greece, with some evi-
dence that they could be affected by a scrapie strain dif-
ferent from those previously studied in Italy, France and
Greece, from which K222 carriers could not have been
protected [11]. No data are currently available regarding
the K222 variant and BSE and atypical scrapie. In Italy,
a Nor98 positive goat carrying K222 in linkage with
H154 was found, suggesting that K222 might not confer
resistance to atypical scrapie [18]. Similarly, in a highly
scrapie-affected Greek herd, a unique C- and N-termin-
ally truncated protease resistant PrP fragment, which
has been suggested to be a marker of an unrecognized
prion protein disorder, was identified in clinically
healthy goats, including Q/K 222 animals as well [47].
One limitation of the present study was the lack of
homozygous K/K222 animals. The role of homozygotes
needs to be investigated to verify whether there could
be a situation like that in sheep, where ARR/ARR ani-
mals are highly resistant, while some cases of disease are
occasionally reported in ARR/XXX [48]. Barillet et al.
[14] estimated the risk for Q/K 222 goats as being
within a similar range as the risk for ARR/ARQ sheep,
comparing them to their respective wild type genotypes.
Moreover, the study on cell-free conversion showed that
recombinant K222 alone abolished conversion and sig-
nificantly reduced conversion in a condition of simu-
lated heterozygosis, i.e., in co-incubation with another
PrP variant [46]. These results thus suggest that K/K
222 homozygotes should be more resistant than hetero-
zygotes against classical scrapie, even if only experimen-
tal challenges can exclude the possible phenomenon of
overdominance, as observed in the susceptibility of mice
to several scrapie strains [49].
Another open question in the present study is whether
negative K222 goats can be healthy carriers of infection.
To answer this, the negative tissues of the challenged
Q/K 222 goats will be tested by bioassay for the pre-
sence of infectivity.
Other experimental challenge studies on the K222 var-
iant are underway in Europe [23]. If they obtain the
same results as ours in other breeds and with other
strains including BSE, it will be possible to implement
breeding programs to control classical scrapie in goats
in the near future.
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